Web Content Viewer

Actions

Canon U.S.A. to Display Teleretinal Imaging Capability at AADE 2017


MELVILLE, N.Y., August 1, 2017 – Showcasing its teleretinal imaging solution and eye care devices, Canon U.S.A., Inc., a leader in digital imaging solutions, has announced that it will attend the annual meeting of the American Association of Diabetes Educators (AADE), held from Friday, August 4 to Monday, August 7 in Indianapolis, Indiana. Guests are encouraged to visit booth #1441 to see first-hand the capabilities of Canon eye screening technology.

Among the products on display within the Canon booth will be the CR-2 PLUS AF Digital Non-Mydriatic Retinal camera and imageSPECTRUM Image Management System software1, an intuitive software solution offering image management and portability to help improve workflow, which is sold separately. By using the CR-2 PLUS AF retinal camera with imageSPECTRUM software, healthcare professionals using either the Windows® 7 with SQL 2012 or Windows 10 with SQL 2016 operating system can perform retinal screenings and then quickly transmit the images to doctors' offices thousands of miles away, both domestic and abroad2, to assist in making a diagnosis.

The CR-2 PLUS AF camera can help healthcare professionals capture ultra-high resolution images efficiently. Utilizing advanced Canon EOS optics and CMOS image-capture technology, the CR-2 PLUS AF camera features a customized 20.2 megapixel digital camera. With the press of a button, users can switch between auto and manual focusing for ultimate control and ease-of-use. The Auto Capture function determines the appropriate moment to capture an image by analyzing when exposure and alignment are ideal.

In addition to the CR-2 PLUS AF camera’s ability to capture high-resolution color retinal images, the imageSPECTRUM software, which is sold separately, includes a set of digital RGB filters to assist with the viewing of suspect pathologies and an opacity suppression tool to help provide clear images of the eye. The CR-2 PLUS AF camera includes a non-invasive Fundus Autofluorescence imaging mode that provides the reviewer with the ability to quickly assess the condition of the RPE layer.

For more information about Canon eye care devices and solutions, please visit http://www.usa.canon.com/eye-care.

About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately $29 billion in global revenue, its parent company, Canon Inc. (NYSE:CAJ), ranks third overall in U.S. patents granted in 2016.† Canon U.S.A. is committed to the highest level of customer satisfaction and loyalty, providing 100 percent U.S.-based consumer service and support for all of the products it distributes in the United States. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. In 2014, the Canon Americas Headquarters secured LEED® Gold certification, a recognition for the design, construction, operations and maintenance of high-performance green buildings. To keep apprised of the latest news from Canon U.S.A., sign up for the Company's RSS news feed by visiting www.usa.canon.com/rss and follow us on Twitter @CanonUSA. For media inquiries, please contact pr@cusa.canon.com.

#  #  #  

Based on weekly patent counts issued by United States Patent and Trademark Office.

Availability and specifications subject to change without notice.

1 Requires Windows 7 with SQL 2012 or Windows 10 with SQL 2016 operating system. Windows is either a registered trademark or trademark of Microsoft Corporation in the United States and/or other countries.

2 Requires internet access and imageSPECTRUM Image Management System software to both send and receive data.